Most Read Articles
15 Feb 2016
New drug applications approved by US FDA as of 1 - 15 Feb 2016 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
07 Sep 2016
Topical drugs with higher efficacy coefficients, as measured by minimum inhibitory concentration (MIC) in a keratin-containing media, are more effective against onychomycosis, a new study finds.
01 Sep 2016
Pembrolizumab is superior to chemotherapy for sustaining health-related quality of life(HRQoL) in ipilimumab-refractory advanced melanoma patients, the KEYNOTE-002 study shows.
01 Jul 2013

Acne is particularly prevalent during adolescence, and some teenagers will face an on-going battle with this common skin condition.

Melasma and Acne: Getting the Treatments Right

08 Nov 2016
At the 7th Galderma Skin Day, renowned dermatologists, Dr Derrick Aw of the National University Hospital, Singapore and Dr Chan Lee Chin of Penang Hospital, shared practice pearls on managing melasma and acne. 

Related MIMS Drugs

Editor's Recommendations
Most Read Articles
15 Feb 2016
New drug applications approved by US FDA as of 1 - 15 Feb 2016 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
07 Sep 2016
Topical drugs with higher efficacy coefficients, as measured by minimum inhibitory concentration (MIC) in a keratin-containing media, are more effective against onychomycosis, a new study finds.
01 Sep 2016
Pembrolizumab is superior to chemotherapy for sustaining health-related quality of life(HRQoL) in ipilimumab-refractory advanced melanoma patients, the KEYNOTE-002 study shows.
01 Jul 2013

Acne is particularly prevalent during adolescence, and some teenagers will face an on-going battle with this common skin condition.